Kim Young-Ho, Min Byung-Hoon, Choi Hyo Kyung, Kim Sue Jin, Kim Kyoung-Mee, Kim Jin Yong, Chang Dong Kyung, Son Hee Jung, Rhee Poong-Lyul, Kim Jae J, Rhee Jong Chul, Chun Ho-Kyung
Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul 35-710, South Korea.
J Surg Oncol. 2009 May 1;99(6):351-5. doi: 10.1002/jso.21239.
The biologic significance of low-level microsatellite instability (MSI) in colorectal cancers (CRCs) remains unclear. This study aimed to elucidate whether sporadic MSI-low CRCs in Korea displayed distinguished clinicopathological characteristics from microsatellite stable (MSS) and MSI-high CRCs.
We consecutively enrolled 657 patients who underwent their first surgical resections for stage I-IV sporadic CRCs and compared their clinicopathological features and prognosis after resection according to MSI status (574 MSS, 30 MSI-low and 53 MSI-high CRCs).
When compared with MSS CRCs, MSI-low CRCs showed significantly more frequent association with poorly differentiated histology, mucinous carcinoma, and large tumour size. In addition, MSI-low CRCs demonstrated significantly less frequent lymph node metastasis and advanced tumour stage than MSS CRCs. When compared with MSI-high CRCs, MSI-low CRCs were significantly more frequently located in distal colon. Three-year overall and disease-free survival rates of MSS, MSI-low and MSI-high CRCs were 83.5%, 90.0% and 91.7% and 82.0%, 89.1% and 87.5%, respectively and neither demonstrated significant difference between three groups.
These results indicated that sporadic MSI-low CRCs in Korea displayed distinguished clinicopathological features and might form a distinct subgroup especially from MSS CRCs. Further large studies are required to evaluate the impact of MSI-low status on prognosis.
结直肠癌(CRC)中低水平微卫星不稳定性(MSI)的生物学意义仍不清楚。本研究旨在阐明韩国散发性微卫星低度不稳定结直肠癌(MSI-low CRC)是否具有与微卫星稳定(MSS)和微卫星高度不稳定结直肠癌(MSI-high CRC)不同的临床病理特征。
我们连续纳入了657例接受I-IV期散发性CRC首次手术切除的患者,并根据MSI状态(574例MSS、30例MSI-low和53例MSI-high CRC)比较了他们的临床病理特征和切除后的预后。
与MSS CRC相比,MSI-low CRC与低分化组织学、黏液癌和大肿瘤大小的关联更为频繁。此外,与MSS CRC相比,MSI-low CRC的淋巴结转移和肿瘤晚期的发生率明显较低。与MSI-high CRC相比,MSI-low CRC更常位于结肠远端。MSS、MSI-low和MSI-high CRC的三年总生存率和无病生存率分别为83.5%、90.0%和91.7%以及82.0%、89.1%和87.5%,三组之间均无显著差异。
这些结果表明,韩国散发性MSI-low CRC具有独特的临床病理特征,可能构成一个独特的亚组,尤其是与MSS CRC不同。需要进一步的大型研究来评估MSI-low状态对预后的影响。